Loading clinical trials...
Loading clinical trials...
Phase II Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in Epidermolysis Bullosa.
Conditions
Interventions
Dentoxol mouthrinse dosages
Locations
1
Chile
Facultad de Odontología, Universidad de Chile
Santiago, Santiago Metropolitan, Chile
Start Date
April 6, 2022
Primary Completion Date
August 1, 2022
Completion Date
March 1, 2023
Last Updated
April 14, 2022
NCT06423573
NCT05449548
NCT06330350
NCT05157958
NCT03526159
NCT07050810
Lead Sponsor
University of Chile
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions